View source for Protein C, human (Ceprotin)

Human protein C

==History of changes in EMA indication==
*2001-07-16: Initial authorization as Ceprotin
*Uncertain date: CEPROTIN is indicated for prophylaxis and treatment of purpura fulminans, coumarin-induced skin necrosis, and venous thrombotic events in patients with severe congenital protein C deficiency.

==Also known as==
*'''Brand name:''' Ceprotin

[[Category:Drugs]]
[[Category:Fractionated plasma products]]
[[Category:Intravenous medications]]

[[Category:Hematology medications]]
[[Category:Hemostasis medications]]
[[Category:Anticoagulation factors]]
[[Category:EMA approved in 2001]]
[[Category:Stub]]